Alibaba Health Information Technology Limited
ALBHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $30,598,292 | $27,026,555 | $26,763,016 | $20,577,616 |
| % Growth | 13.2% | 1% | 30.1% | – |
| Cost of Goods Sold | $23,166,201 | $21,131,234 | $21,061,682 | $16,469,623 |
| Gross Profit | $7,432,091 | $5,895,321 | $5,701,334 | $4,107,993 |
| % Margin | 24.3% | 21.8% | 21.3% | 20% |
| R&D Expenses | $720,053 | $705,382 | $677,822 | $728,828 |
| G&A Expenses | $390,593 | $359,980 | $379,487 | $395,082 |
| SG&A Expenses | $2,648,967 | $2,136,544 | $2,148,162 | $2,376,361 |
| Sales & Mktg Exp. | $2,258,374 | $1,776,564 | $1,768,675 | $1,981,279 |
| Other Operating Expenses | $2,487,008 | $2,335,992 | $2,824,104 | $2,021,650 |
| Operating Expenses | $5,856,028 | $5,177,918 | $5,650,088 | $5,126,839 |
| Operating Income | $1,576,063 | $717,403 | -$31,787 | -$1,098,434 |
| % Margin | 5.2% | 2.7% | -0.1% | -5.3% |
| Other Income/Exp. Net | -$16,095 | $221,996 | $582,781 | $0 |
| Pre-Tax Income | $1,559,968 | $939,399 | $550,994 | -$252,514 |
| Tax Expense | $127,954 | $56,263 | $14,485 | $13,427 |
| Net Income | $1,432,427 | $883,477 | $535,653 | -$265,555 |
| % Margin | 4.7% | 3.3% | 2% | -1.3% |
| EPS | 0.089 | 0.063 | 0.04 | -0.02 |
| % Growth | 42.1% | 57.9% | 301.5% | – |
| EPS Diluted | 0.089 | 0.063 | 0.04 | -0.02 |
| Weighted Avg Shares Out | 16,070,670 | 14,090,767 | 13,503,051 | 13,480,634 |
| Weighted Avg Shares Out Dil | 16,135,804 | 14,090,693 | 13,541,580 | 13,482,634 |
| Supplemental Information | – | – | – | – |
| Interest Income | $464,849 | $478,030 | $331,588 | $209,764 |
| Interest Expense | $2,609 | $5,969 | $5,833 | $3,815 |
| Depreciation & Amortization | $57,605 | $53,682 | $27,027 | $60,576 |
| EBITDA | $1,620,182 | $999,050 | -$24,477 | -$188,123 |
| % Margin | 5.3% | 3.7% | -0.1% | -0.9% |